abs166.txt	objective		the	anti-cancer	anthracycline	drug	doxorubicin	(dox)	causescardiotoxicity	we	investigated	role	of	protease-activated	receptor	1	(par-1)in	dox-induced	cardiotoxicity	methods	and	results	in	vitro	experiments	revealed	that	par-1	enhanceddox-induced	mitochondrial	dysfunction	reactive	oxygen	species	cell	death	ofcardiac	myocytes	cardiac	fibroblasts	contribution	todox-induced	was	by	subjecting	par-1-/-	mice	andpar-1+/+	to	acute	chronic	exposure	dox	heart	function	measuredby	echocardiography	exhibited	significant	less	injury	anddysfunction	compared	par-1+/+	after	administration	had	reduced	levels	nitrotyrosine	apoptosis	inflammation	intheir	furthermore	inhibition	inwild-type	with	vorapaxar	significantly	dox-inducedcardiotoxicity	conclusion	our	indicate	activation	contributes	may	be	a	new	approach	reducedox-induced	cancer	patients
